SCHEMBL29375137

SCHEMBL29375137

CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
SOAT1 P35610 3/20 0.35
PSMB11 A5LHX3 1/20 0.34
PSMA7 O14818 1/20 0.34
PSMB1 P20618 1/20 0.34
PSMA1 P25786 1/20 0.34
PSMA2 P25787 1/20 0.34
PSMA3 P25788 1/20 0.34
PSMA4 P25789 1/20 0.34
PSMB8 P28062 1/20 0.34
PSMB9 P28065 1/20 0.34
PSMA5 P28066 1/20 0.34
PSMB4 P28070 1/20 0.34
PSMB6 P28072 1/20 0.34
PSMB5 P28074 1/20 0.34
PSMB10 P40306 1/20 0.34
PSMB3 P49720 1/20 0.34
PSMB2 P49721 1/20 0.34
PSMA6 P60900 1/20 0.34
PSMA8 Q8TAA3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30819201 1.00 KDM4E (0.38) KDM4ESOAT1PSMB11PSMA7PSMB1
SCHEMBL17867100 1.00 KDM4E (0.38) KDM4ESOAT1PSMB11PSMA7PSMB1
SCHEMBL29885671 0.95 PSMB11 (0.38) KDM4EPSMB11PSMA7PSMB1PSMA1
SCHEMBL29885414 0.92 SOAT2 (0.41) SOAT1GHSRSOAT2
SCHEMBL16500668 0.84 KDM4E (0.47) KDM4ESOAT1ALDH1A1CYP3A4CYP2C9
SCHEMBL6466586 0.84 KDM4E (0.47) KDM4ESOAT1ALDH1A1CYP3A4CYP2C9
SCHEMBL29717170 0.84 KDM4E (0.47) KDM4ESOAT1ALDH1A1CYP3A4CYP2C9
SCHEMBL29375200 0.84 PSMB11 (0.46) SOAT1PSMB11PSMA7PSMB1PSMA1
SCHEMBL13637393 0.84 KDM4E (0.39) KDM4ESOAT1ALDH1A1CYP3A4CYP2C9
SCHEMBL2869111 0.83 HRH3 (0.39) ALDH1A1MLNRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12102653-B2 Ligand regulated protein-protein interaction system ST. ANNA KINDERKREBSFORSCHUNG (AT) 2024-10-01 US disclosed
US-20240000841-A1 LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM ST ANNA KINDERKREBSFORSCHUNG (AT) 2024-01-04 US disclosed
US-11844813-B2 Ligand regulated protein-protein interaction system ST. ANNA KINDERKREBSFORSCHUNG (AT) 2023-12-19 US disclosed
US-11421223-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2022-08-23 US disclosed
US-20220041687-A1 A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) ST. ANNA KINDERKREBSFORSCHUNG (AT) 2022-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220041687-A1 A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) CARS1, CD74, HAVCR2 KDM4E 4271/4885SOAT1 3647/4885PSMB11 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.